CITIUS PHARMACEUTICALS INC

CTXR Stock Slides 6.31% Amid Volatile Biotech Market, Below 200‑Day SMA

CTXR shares drop 6.3% to $0.40 amid a 34.8% monthly decline; Citius Pharmaceuticals faces a long‑term 200‑day SMA hit, with volatility mirrored across biopharma peers.

CITIUS PHARMACEUTICALS INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Jake Connors

24/10/2026, 01:24

2 minutes to read

CTXR Market Update: Citius Pharma Shares Fall 25% Amid Competitive Landscape

CTXR market update: Citius Pharma’s stock dips 6.96% to $0.42, a 25.82% fall from last month, with key peers in biotech trading amid regulatory moves.

CITIUS PHARMACEUTICALS INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Elliot Mercer

20/10/2026, 17:45

One minute to read